摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(4-氯苯基)氨基甲酰]苯甲酸 | 7142-94-1

中文名称
2-[(4-氯苯基)氨基甲酰]苯甲酸
中文别名
——
英文名称
N-(4-chlorophenyl)phthalamic acid
英文别名
2-[(4-chlorophenyl)aminocarbonyl]benzoic acid;N-(4-chloro-phenyl)-phthalamic acid;N-(4-Chlor-phenyl)-phthalamidsaeure;Phthalsaeure-mono-(4-chlor-anilid);2-[(4-Chlorophenyl)carbamoyl]benzoic acid
2-[(4-氯苯基)氨基甲酰]苯甲酸化学式
CAS
7142-94-1
化学式
C14H10ClNO3
mdl
——
分子量
275.691
InChiKey
WJSPLHRLEZJTRR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2924299090

SDS

SDS:e068c68257a5afc44871d92c00f5f8ac
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[(4-氯苯基)氨基甲酰]苯甲酸 在 sodium tetrahydroborate 、 sodium acetate乙酸酐 作用下, 以 甲醇 为溶剂, 反应 1.0h, 生成 2-(4-chlorophenyl)-3-hydroxyisoindolin-1-one
    参考文献:
    名称:
    Aza-Diels–Alder reaction between N-aryl-1-oxo-1H-isoindolium ions and tert-enamides: Steric effects on reaction outcome
    摘要:

    报告了在路易斯酸催化的无水条件下,通过[4 + 2]亚胺-狄尔斯-阿尔德环化反应,从N-芳基-3-羟基异喹啉酮和N-乙烯基内酰胺合成5-取代-6,6a-二氢异喹诺[2,1-a]喹啉-11(5H)-酮的方法。在相同条件下,N-(2-取代-芳基)-3-羟基异喹啉酮与N-乙烯基吡咯烷酮的反应导致了2-(2-取代-芳基)-3-(2-(2-氧代吡咯烷-1-基)乙烯基)异喹啉-1-酮类似物的形成,表明立体阻碍是导致偏差的原因。基于X射线晶体学和分子建模结果,讨论了反应的可能机制。

    DOI:
    10.3762/bjoc.10.81
  • 作为产物:
    描述:
    邻苯二甲酸单甲酯sodium hydroxide 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 25.0h, 生成 2-[(4-氯苯基)氨基甲酰]苯甲酸
    参考文献:
    名称:
    Structure-Based Optimization of a Non-β-lactam Lead Results in Inhibitors That Do Not Up-Regulate β-Lactamase Expression in Cell Culture
    摘要:
    Bacterial expression of beta-lactamases is the most widespread resistance mechanism to beta-lactam antibiotics, such as penicillins and cephalosporins. There is a pressing need for novel, non-beta-lactam inhibitors of these enzymes. One previously discovered novel inhibitor of the beta-lactamase AmpC, compound 1, has several favorable properties: it is chemically dissimilar to beta-lactams and is a noncovalent, competitive inhibitor of the enzyme. However, at 26 microM its activity is modest. Using the X-ray structure of the AmpC/1 complex as a template, 14 analogues were designed and synthesized. The most active of these, compound 10, had a K(i) of 1 microM, 26-fold better than the lead. To understand the origins of this improved activity, the structures of AmpC in complex with compound 10 and an analogue, compound 11, were determined by X-ray crystallography to 1.97 and 1.96 A, respectively. Compound 10 was active in cell culture, reversing resistance to the third generation cephalosporin ceftazidime in bacterial pathogens expressing AmpC. In contrast to beta-lactam-based inhibitors clavulanate and cefoxitin, compound 10 did not up-regulate beta-lactamase expression in cell culture but simply inhibited the enzyme expressed by the resistant bacteria. Its escape from this resistance mechanism derives from its dissimilarity to beta-lactam antibiotics.
    DOI:
    10.1021/ja042984o
点击查看最新优质反应信息

文献信息

  • The cyclisation of substituted phthalanilic acids in acetic acid solution. A kinetic study of substituted N-phenylphthalimide formation
    作者:Christopher J. Perry、Zahida Parveen
    DOI:10.1039/b008399m
    日期:——
    One novel and ten known substituted 3′- and 4′-phthalanilic acids have been prepared. These have been cyclised to two novel and nine known substituted N-phenylphthalimides by heating with glacial acetic acid. Both phthalanilic acids and imides have been characterised in detail and spectroscopic data are given. The kinetics of cyclisation for phthalanilic acids has been examined in detail, and it has
    已经制备了一种新颖的和十种已知的取代的3'-和4'-邻苯二酸。通过加热,将它们环化为两个新的和九个已知的取代的N-苯基邻苯二甲酰亚胺。冰醋酸。邻苯二酸和酰亚胺已经详细描述了特征并给出了光谱数据。的动力学环化对苯二酸的苯酚进行了详细的研究,结果发现一个复杂的机理正在发挥作用。最初涉及的是可逆的溶剂 辅助分子内亲核攻击 酰胺 氮 在 羧酸 羰。明确的证据表明,存在长寿命的中间体可以作为前体酰亚胺编队。使用快速预平衡模型对观察到的动力学进行合理化,然后将中间体缓慢分解为酰亚胺。观察到的用于预平衡的速率常数显示出行为良好的线性Hammett图(ρ  = -1.1),而用于形成酰亚胺 不要。
  • Water mediated, environmentally friendly, step-wise, tandem & one-pot syntheses of 2-(1H-benzo[d]imidazole-2-yl)-N-arylbenzamides
    作者:Yervala Dathu Reddy、Chittireddy Venkata Ramana Reddy、Pramod Kumar Dubey
    DOI:10.1039/c3ra44423f
    日期:——
    Water mediated and environmentally friendly, step-wise, tandem & one-pot syntheses of 2-(1H-benzo[d]imidazole-2-yl)-N-arylbenzamide derivatives have been developed by simply combining phthalic anhydride, anilines and phenylenediammonium dihydrogenphosphate. This reaction has an easy workup, provides excellent yields, and uses water as the solvent which is considered to be relatively environmentally benign.
    通过简单地将邻苯二甲酸酐、苯胺和苯二磷酸二氢铵结合在一起,开发出了以水为介质的 2-(1H-苯并[d]咪唑-2-基)-N-芳基苯甲酰胺衍生物的环保型一步串联和一锅合成法。该反应易于操作,产量极高,并使用水作为溶剂,被认为对环境相对无害。
  • [EN] PHTHALANILATE COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS DE PHTALANILATE ET LEURS PROCÉDÉS D'UTILISATION
    申请人:UNIV NOTRE DAME DU LAC
    公开号:WO2011026107A1
    公开(公告)日:2011-03-03
    The invention provides antimicrobial compounds and compositions, and methods of using them. The compounds and compositions include, for example, a compound of any one of Formulas I-X. The invention further provides methods of preparing the compounds, and useful intermediates for their preparation. The compounds can possess highly specific and selective activity, such as antibacterial activity and/or enzymatic inhibitory activity. Accordingly, the compounds and compositions can be used to treat bacterial infections, or to inhibit or kill bacteria, either in vitro or in vivo.
    本发明提供了抗微生物化合物和组合物,以及使用它们的方法。这些化合物和组合物包括,例如,I-X公式中的任何一种化合物。本发明进一步提供了制备这些化合物的方法,并提供了有用的中间体。这些化合物可以具有高度特异性和选择性活性,例如抗菌活性和/或酶抑制活性。因此,这些化合物和组合物可以用于治疗细菌感染,或者在体外或体内抑制或杀死细菌。
  • Kumar, Padam Praveen; Rama Devi; Dubey, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2013, vol. 52, # 8, p. 1166 - 1171
    作者:Kumar, Padam Praveen、Rama Devi、Dubey
    DOI:——
    日期:——
  • Kumar, Padam Praveen; Reddy, Y. Dathu; Kumari, Y. Bharathi, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53, # 4, p. 392 - 398
    作者:Kumar, Padam Praveen、Reddy, Y. Dathu、Kumari, Y. Bharathi、Devi, B. Rama、Dubey
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐